banner add

Revenues Down and Stock Battered as Data Firm Faces Scrutiny

MultiPlan has helped big health insurers make billions by reducing reimbursements for medical bills, but its business model is now being questioned.

from NYT > Health https://ift.tt/sBLwog6
via IFTTT

No comments

New Amgen Drug MariTide Shows Promising Weight Loss in Early Data

The drug, which is named MariTide and delivered in a monthly injection, is years from being sold, but caused an average of up to 20 percent ...

Theme images by PLAINVIEW. Powered by Blogger.